Skip to main content

Table 3 Build up phase with administration of omalizumab

From: Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab

Week no. Premedication Omalizumab (mg) HB venom cumulative dose (mcg) Adverse reactions
1   150   
3   300   
4 Terfenadine   4.11 None
5 Terfenadine 300 10 Cough and dysphagia
6 Hydrocortisone
Ranitidine
Cetirizine
  20 None
7 Hydrocortisone
Ranitidine
Cetirizine
300 30 Ocular and palmar itching
8   300   
9 Hydrocortisone
Ranitidine
Cetirizine
  45 None
10 Hydrocortisone
Ranitidine
Cetirizine
300 60 None
11 Hydrocortisone
Ranitidine
Cetirizine
  80 None
12   300   
13 Hydrocortisone
Ranitidine
Cetirizine
  100 None
14 Hydrocortisone
Ranitidine
Cetirizine
300 130 None
15 Hydrocortisone
Ranitidine
Cetirizine
  170 None
16 Hydrocortisone
Ranitidine
Cetirizine
300 200 None